
Akbarali Padiyath Mohammed
About Akbarali Padiyath Mohammed
Data last updated:
Akbarali Padiyath Mohammed is a Director at Arkgen Pharma Private Limited (since 2014) and Additional Director at Arkgen Enterprises Private Limited (since 2016). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹17.85 Cr; the largest is Arkgen Pharma Private Limited at ₹16.92 Cr (FY 2025). Earlier, Akbarali Padiyath Mohammed was a Director at Srini Pharmaceuticals Private Limited (2010–2014) and Managing Director at Apotex Pharmachem India Private Limited (2005–2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Jul 2014 | 2014 | ₹16.92 Cr (FY 2025) | Active | |
| Additional Director | 19 May 2016 | 2005 | ₹92.7 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Sep 2010 | 1995 | ₹166 Cr (FY 2024) | Active | |
| Managing Director | 11 Mar 2005 | 2003 | ₹142 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Akbarali Padiyath Mohammed
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amal Amina Akberali Padiyath | 09326606 | Arkgen Pharma Private Limited | Director |
| Hathika Akbarali | 06875036 | Arkgen Pharma Private Limited , Arkgen Enterprises Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akbarali Padiyath Mohammed
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akbarali Padiyath Mohammed
Akbarali Padiyath Mohammed currently holds 2 directorships: Arkgen Pharma Private Limited (Director, since 30 Jul 2014, revenue ₹16.92 Cr (FY 2025)); Arkgen Enterprises Private Limited (Additional Director, since 19 May 2016, revenue ₹92.7 Lakh (FY 2025)).
Akbarali Padiyath Mohammed was first appointed on 11 Mar 2005 as Managing Director at Apotex Pharmachem India Private Limited. The most recent appointment on record is 19 May 2016 at Arkgen Enterprises Private Limited.
The 2 current companies of Akbarali Padiyath Mohammed that report revenue have a combined latest revenue of ₹17.85 Cr: Arkgen Pharma Private Limited ₹16.92 Cr (FY 2025); Arkgen Enterprises Private Limited ₹92.7 Lakh (FY 2025).
Akbarali Padiyath Mohammed held 2 earlier board appointments: Srini Pharmaceuticals Private Limited (Director, 15 Sep 2010 to 08 May 2014); Apotex Pharmachem India Private Limited (Managing Director, 11 Mar 2005 to 08 May 2014).
The current boards of Akbarali Padiyath Mohammed's companies include Amal Amina Akberali Padiyath (Arkgen Pharma Private Limited), Hathika Akbarali (Arkgen Pharma Private Limited).